Carlos
Garzón Montesinos
Ikertzailea 2016-2017 tartean
![Foto de Carlos](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome
Neurobiology of Disease, Vol. 125, pp. 92-106